Already highly regulated with a risk-based approach at their core, AI-powered medical devices and in vitro diagnostic medical devices face new regulatory constraints stemming from the EU AI Act, a horizontal legal instrument...more
After several months of uncertainty due to amendments made by the Senate and the dissolution of the National Assembly shortly thereafter, France finally passed a law on February 27, 2025, aiming to reduce risks associated...more
3/20/2025
/ Compliance ,
Environmental Policies ,
EU ,
Hazardous Substances ,
New Legislation ,
PFAS ,
Pollution Control ,
Popular ,
Regulatory Requirements ,
Reporting Requirements ,
Toxic Chemicals